Form D · Other
TL Biolabs Corp.
Santa Clara, CA · CIK 0001697205
Offering snapshot reported May 24, 2018 · SEC filing
- Reported sold
- $5.34M Offering amount: $7.49M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 11, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2018 | Initial | $5,342,541 | No comparison | 17 | SEC filing |
| Mar 6, 2017 | Initial | $800,000 | No comparison | 1 | SEC filing |
| Feb 23, 2017 | Initial | $3,420,768 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-313227
Source: Form D, filed May 24, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Zal Bilimoria | Director |
| Fred Turner | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
3511 Thomas Road, Suites 6 & 7
Santa Clara, CA, 95054
Santa Clara, CA, 95054